Pure Global

Qualitative blood group antigen test card for ABO and Rh(D) and detection of abnormal antibodies - Vietnam Registration 2403572ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Qualitative blood group antigen test card for ABO and Rh(D) and detection of abnormal antibodies in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2403572ĐKLH/BYT-HTTB and manufactured by Haemokinesis Limited. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN THIẾT BỊ Y TẾ VIMEC.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2403572ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2403572ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qualitative blood group antigen test card for ABO and Rh(D) and detection of abnormal antibodies
VN: Thẻ xét nghiệm định tính kháng nguyên nhóm máu hệ ABO và Rh(D) và phát hiện kháng thể bất thường
Risk Class TTBYT Loại D

Registration Details

2403572ĐKLH/BYT-HTTB

000.00.04.G18-230809-0007

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Haemokinesis Limited

Technical Details

The card for determining blood type is used to test the combination of ABO and Rh(D) blood group antigens. The STARGEL10 Crossmatch card allows for the confirmation of the ABO/Rh(D) blood type of both the recipient and the donor or just the recipient, along with the detection of clinically significant donor-specific antibodies using the recipient's red blood cells and plasma in the IAT and autoIAT tests. The test reagents used by trained personnel.

Dates and Status

Nov 14, 2024